Caribou Biosciences (CRBU) Short-term Investments (2021 - 2026)

Caribou Biosciences (CRBU) has 6 years of Short-term Investments data on file, last reported at $105.6 million in Q1 2026.

• Quarterly Short-term Investments fell 41.04% year-over-year to $105.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $105.6 million (down 41.04% YoY) and the FY2025 annual result came in at $127.0 million, down 34.29% from the prior year.
• Short-term Investments eased to $105.6 million in Q1 2026 per CRBU's latest filing, from $127.0 million in the prior quarter.
• Across five years, Short-term Investments topped out at $277.7 million in Q4 2023 and bottomed at $105.6 million in Q1 2026.
• The 5-year median for Short-term Investments is $193.2 million (2024), against an average of $192.9 million.
• The widest annual swing landed in 2023, when Short-term Investments jumped 46.66%; it then sank 41.04% in 2026.
• Tracing CRBU's Short-term Investments over 5 years: stood at $189.3 million in 2022, then soared by 46.66% to $277.7 million in 2023, then sank by 30.4% to $193.2 million in 2024, then sank by 34.29% to $127.0 million in 2025, then declined by 16.86% to $105.6 million in 2026.
• Per Business Quant, the three latest CRBU Short-term Investments figures stand at $105.6 million (Q1 2026), $127.0 million (Q4 2025), and $136.1 million (Q3 2025).

Peer Comparison